Company Search:
Advanced Search
Sponsored Links
Kancera AB Company Snapshot
Kancera AB operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kancera AB with three other pharmaceutical manufacturers in Europe: StenoCare A/S (2020 sales of 277,780.14 Swedish Kronor [US$32,191.94 ] ), Hemcheck Sweden AB (306,810.00 Swedish Kronor [US$35,556.21 ] ), and Index Pharmaceuticals Holding Ab (35,000.00 Swedish Kronor [US$4,056.15 ] ).

Sales Analysis. Sales fell dramatically in 2020: Kancera AB reported sales of SEK 90,000.00 (US$10.43 thousand) for the year ending December of 2020. This represents a sharp decrease of 97.2% versus 2019, when the company's sales were SEK 3.22 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kancera AB
  Stock Performance Chart for Kancera AB
  Stock Data: Recent Stock Performance:
  Current Price (4/1/2021): 18.02
(Figures in Swedish Kronor)
1 Week -7.3%   13 Weeks 2.0%  
4 Weeks 10.4%   52 Weeks 383.8%  
Kancera AB Key Data:
  Ticker: KAN Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2020 Sales 90,000
(Year Ending Jan 2021).
Employees: 20
  Currency: Swedish Kronor Market Cap: 854,499,390
  Fiscal Yr Ends: December Shares Outstanding: 47,419,500
  Share Type: AKTIER Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.